A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma

Alberto S. Pappo, Laura C. Bowman, Wayne L. Furman, Bhaskar N. Rao, Larry E. Kun, Jesse J. Jenkins, William R. Crom, Xiaolong Luo, Sue C. Kaste, Loraine Avery, William H. Meyer, David N. Shapiro, William M. Crist